Context Therapeutics Inc. (CNTX) vs MIRA Pharmaceuticals, Inc. (MIRA)

A side-by-side comparison of Context Therapeutics Inc. and MIRA Pharmaceuticals, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

Compare
Context Therapeutics Inc. logo
CNTX
Context Therapeutics Inc.
$31M
$0.33HealthcareDelayed quote: Oct 6, 2026, 10:55 AM EDT
MIRA Pharmaceuticals, Inc. logo
MIRA
MIRA Pharmaceuticals, Inc.
$31M
$0.75HealthcareDelayed quote: Oct 6, 2026, 10:54 AM EDT

Total return — CNTX vs MIRA

growth of $100 · dividends reinvested · last 3y
CNTX -70.7% (-33.6%/yr)MIRA -88.5% (-51.4%/yr)CNTX compounded faster over this window
0100200300Start $100202420252026$29$11
CNTX MIRA

CNTX vs MIRA: by the numbers

  • •MIRA is the larger company ($31M vs $31M market cap).

Metrics side by side

Valuation

MetricCNTXMIRA
P/B ratio0.803.84

Profitability

MetricCNTXMIRA
Gross margin0.00%0.00%
Operating margin0.00%0.00%
Net margin0.00%0.00%
ROE-120.40%-116.14%
ROIC-126.84%-115.18%

Go deeper

Full CNTX analysisFull MIRA analysisInteractive comparison tool

Dig into the metrics

Context Therapeutics ROEMIRA Pharmaceuticals ROEContext Therapeutics operating marginMIRA Pharmaceuticals operating marginContext Therapeutics revenue growthMIRA Pharmaceuticals revenue growthContext Therapeutics free cash flowMIRA Pharmaceuticals free cash flow

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.